Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway
Imatinib (IM) is highly effective in treatment of chronic myeloid leukemia (CML) but does not eliminate minimal residual disease (MRD), which remains a potential source of relapse. IM treatment… Expand
Sufficient for the Development of NK T Cells Expression of CD1d2 on Thymocytes Is Not
- C. Wang, S. Cardell, +5 authors L. Zhao
- Chemistry
- 2013